![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625](https://c8.alamy.com/comp/2D1WY6T/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-collects-his-papers-following-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuterswolfgang-rattay-germany-tags-business-2D1WY6T.jpg)
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
![Ratiopharm Ulm win at the overtime against Venezia after impressive comeback / News - Basketnews.com Ratiopharm Ulm win at the overtime against Venezia after impressive comeback / News - Basketnews.com](https://m.basketnews.com/image-333617-crop700x700.jpg)
Ratiopharm Ulm win at the overtime against Venezia after impressive comeback / News - Basketnews.com
![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625](https://l450v.alamy.com/450v/2d24j7y/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-addresses-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuterswolfgang-rattay-germany-tags-business-2d24j7y.jpg)
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. buttons up his suite following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. buttons up his suite following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for](https://c8.alamy.com/zooms/6/da7936e38fba4dcdb5e38a469f387087/2e76876.jpg)
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. buttons up his suite following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for
![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625](https://l450v.alamy.com/450v/2d2axtn/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-reacts-during-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuterswolfgang-rattay-germany-tags-business-headshot-2d2axtn.jpg)